Magenta Therapeutics Inc.

NASDAQ: MGTA · Real-Time Price · USD
0.70
-0.06 (-7.69%)
At close: Sep 11, 2023, 10:00 PM

Magenta Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.03 -0.02 -3.97
PEG Ratio
n/a -0.00 0.18
PS Ratio
0.44 n/a n/a
PB Ratio
0.01 0.01 1.51
P/FCF Ratio
-0.03 -0.02 -4.28
P/OCF Ratio
-0.03 -0.02 -4.38
OCF/S Ratio
-12.54 n/a n/a
Debt / Equity Ratio
0.00 0.28 n/a
Quick Ratio
15.22 7.95 16.29
Current Ratio
15.22 7.95 16.29
Asset Turnover
0.02 n/a n/a
Interest Coverage
n/a 18.22 n/a
Return on Equity
-0.24 -0.68 -0.38
Return on Assets
-0.23 -0.49 -0.35
Return on Invested Capital
-0.29 -0.56 -0.38
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a n/a n/a
Net Profit Margin
-13.63 n/a n/a
Pretax Profit Margin
-13.63 n/a n/a
Operating Profit Margin
-16.34 n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
-16.34 n/a n/a